Why The U.S. Response To Hantavirus Could Signal Future Trouble
An outbreak of hantavirus, linked to the Andes strain, has affected passengers on a cruise ship departing Argentina, resulting in at least three deaths and 18 Americans under monitoring. While experts say hantavirus is unlikely to cause a pandemic, the U.S. response has been criticized as disjointed and late. Policy experts attribute this to CDC staff cuts, the U.S. withdrawal from the WHO, and a lack of clear CDC leadership under the Trump administration.
Summary
As of mid-May, 18 Americans are being monitored for hantavirus following an outbreak aboard a cruise ship that departed Argentina and spent weeks off the coast of Africa. At least 11 cases have been confirmed, with three deaths reported. The outbreak is believed to have originated with a Dutch couple on a birdwatching trip who were exposed to a rat species known to carry the virus.
Experts have sought to reassure the public that hantavirus differs significantly from Covid-19. It is not a new disease, the medical community understands its transmission, and it is typically not spread person to person — instead requiring direct contact with infected rodents or their droppings. However, this outbreak involves the Andes strain, which is notable for being transmissible between people, distinguishing it from most hantavirus variants. The University of Florida's chief hospital epidemiologist stated that hantavirus cannot spread as easily as Covid-19, and that current containment measures are expected to prevent a large number of cases.
Despite this relatively contained threat, the U.S. response has drawn criticism. A Georgetown health policy professor noted that the CDC, which has historically led responses to viral outbreaks like Ebola and Zika, has been disjointed and slow in addressing this outbreak. Policy experts link this diminished capacity to several factors: the Trump administration cut approximately 10% of CDC staff at the start of 2025, the U.S. completed its withdrawal from the World Health Organization at the start of 2026, and the CDC is currently operating without clear leadership. While hantavirus itself is not expected to reach pandemic scale, the episode has prompted broader concerns about the United States' ability to respond effectively to a future outbreak involving a far more transmissible pathogen.
Key Insights
- The Andes strain of hantavirus, identified in this outbreak, is notable because unlike most hantavirus strains it can transmit between people, making it more concerning than typical hantavirus cases.
- The University of Florida's chief hospital epidemiologist argued that hantavirus cannot transmit as easily as Covid-19 did, and that current containment measures are expected to prevent a large number of cases.
- A Georgetown health policy professor argued that despite the CDC's strong track record on outbreaks like Ebola and Zika, its response to the hantavirus outbreak has been disjointed and late.
- Policy experts attribute the CDC's weakened response capacity to the Trump administration cutting approximately 10% of CDC staff at the start of 2025 and the U.S. completing its withdrawal from the WHO at the start of 2026.
- Health experts agree hantavirus is unlikely to cause pandemic-level concerns, but the outbreak has exposed questions about whether the U.S. is equipped to handle a future disease outbreak that is far more transmissible.
Topics
Transcript
[0:00] As of mid-May, 18 Americans are being monitored for hantavirus after being on a cruise ship that departed Argentina and spent weeks sitting off the coast of Africa. At least 11 cases of the virus have been reported, with three confirmed deaths. It is believed that the first patients aboard the ship were a Dutch couple, who were on a bird watching trip and exposed to a species of rat that is known to carry the virus. Experts say hantavirus is different from Covid and that the public should be less concerned. It's not a new disease. The medical community has a better understanding of how it's transmitted and how to control infections. [0:30] Typically, hantavirus is not spread…
Full transcript available for MurmurCast members
Sign Up to AccessMore from CNBC
Inside China’s Race To Build The World’s Data Centers
China's prefabricated data center manufacturing offers a significant speed advantage over U.S. construction, potentially reducing build times from 2-3 years to 9 months, while the U.S. becomes increasingly dependent on Chinese supply chains despite geopolitical tensions and national security concerns.
How Williams-Sonoma Became One Of Retail’s Best-Performing Stocks
Williams-Sonoma has outperformed the S&P 500 and competitors by leveraging its omnichannel model, focusing on full-price selling to affluent customers, and deploying AI to enhance e-commerce and supply chain efficiency. Despite a sluggish housing market, the company has achieved margin expansion and is pursuing growth opportunities through smaller home furnishings, B2B expansion, and renewed store openings.
Why It’s So Hard To Build An AI Kill Switch
The video explores whether an AI kill switch is technically feasible and practically implementable. While experts acknowledge the need for safety mechanisms, they conclude that a single universal kill switch is impossible due to distributed computing infrastructure, and that comprehensive regulation similar to other industries would be more effective than a technological quick fix.
America’s AI Chip Talent Crisis — Why The U.S. Needs 157,000 More Workers
The U.S. faces a critical shortage of 157,000 semiconductor workers by the end of the decade as major chip manufacturers build advanced fabs domestically. Universities like Purdue and Arizona State are launching hands-on semiconductor programs, while companies are recruiting aggressively and investing heavily in workforce development to close the talent gap that currently exists compared to Asia.
Exclusive look inside SK Hynix's $720 billion AI memory expansion
SK Hynix, the world's leading maker of high-bandwidth memory (HBM) chips for AI, is investing $720 billion to triple production capacity by 2034 in response to unprecedented demand from major tech companies. The company is expanding aggressively across South Korea and into the US, but faces the classical risk of the memory industry's boom-and-bust cycles.